Mounjaro and polycystic ovary syndrome (PCOS)
Medicines Mouniaro (tirzepatide) may be effective in women with polycystic ovary syndrome (PCOS) makes an important contribution to improving metabolic and hormonal balance. As PCOS is often associated with obesity and insulin resistance, treatments that effectively reduce body weight can have a marked positive impact on the course of the disease.
Weight loss improves in many women the body's response to insulinleading to more stable blood sugar levels and a reduction in insulin resistance. This also has a direct impact on hormonal balance, as the elevated levels of androgens responsible for many of the symptoms of PCOS can be reduced.
As a result regulate the menstrual cycle and re-establish ovulationwhich significantly increases the chance of spontaneous conception. For women planning a pregnancy or experiencing infertility, Mounjar treatment can therefore be an important step in preparing the body for conception or improving the success of further fertility treatments.
In addition to its impact on fertility, improved hormone balance can also help to reduce some of the typical symptoms of PCOS, such as acne or excessive hair, and reduce the risk of metabolic complications in the long term.